Walgreens Boots Alliance, Inc. (WBA)
|Net Income (ttm)||-3.14B|
|Ex-Dividend Date||Feb 15, 2023|
|Day's Range||34.48 - 34.84|
|52-Week Range||30.39 - 47.28|
|Price Target||42.12 (+22.11%)|
|Earnings Date||Mar 28, 2023|
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Read... [Read more]
In 2022, WBA's revenue was $132.70 billion, an increase of 0.15% compared to the previous year's $132.51 billion. Earnings were $4.34 billion, an increase of 70.61%.Financial Statements
According to 26 analysts, the average rating for WBA stock is "Hold." The 12-month stock price forecast is $42.12, which is an increase of 22.11% from the latest price.
7 Must-Buy Income Stocks After the Fed Raised Interest Rates Again
When the Federal Reserve raised interest rates again by 25 basis points, investors seeking stable holdings needed to consider income stocks to buy. The Fed's benchmark rate is rising to a range of bet...
Rallies from Walgreens, PVH and McCormick could be a good sign for earnings season, Cramer says
Stocks that rallied Tuesday in response to "less than stellar" quarterly reports could bode well for earnings season, CNBC's Jim Cramer said.
Walgreens stock closes higher on Tuesday following Q2 earnings beat
Yahoo Finance Live reports on higher earnings for Walgreens stock amid the post-Covid backdrop, a drop of Covid vaccines, and a shortage of employees.
Three-Stock Lunch: Lululemon, Walgreens Boots and McCormick
Lee Munson, CIO of Portfolio Wealth Advisors, joins 'Power Lunch' with a breakdown on how to trade Lululemon, Walgreens Boots, and McCormick & Co.
Walgreens Touts Healthcare Transformation As Clinic Acquisitions Quicken
Continuing its transformation from a pharmacy chain to an integrated healthcare platform with a large retail footprint, Walgreens Boots Alliance (WBA) reported progress on its retail clinic initiative...
Advance Trade in Goods Came in Less Low Than Expected
Advance Trade in Goods Came in Less Low Than Expected
Walgreens Boots (WBA) Q2 Earnings Top Estimates, Margins Down
The U.S. Healthcare segment of Walgreens Boots (WBA) grows on key contract wins, continued partnership growth and a strong focus on execution during fiscal Q2.
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Walgreens Boots Alliance (NASDAQ: WBA) is an alluring buy, with the stock trading at only 7.5X earnings and paying more than 5.75% in yield. This combination is among the best in a blue chip stock, an...
Walgreens tops earnings, maintains full-year guidance
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss quarterly earnings for Walgreens.
Walgreens Boots Alliance (WBA) Q2 Earnings and Revenues Surpass Estimates
Walgreens (WBA) delivered earnings and revenue surprises of 5.45% and 4.16%, respectively, for the quarter ended February 2023. Do the numbers hold clues to what lies ahead for the stock?
Walgreens stock rises on Q2 earnings beat
Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb Yahoo Finance Live's Brad Smith breaks down the rise in stock for Walgreens following second-quarter earnings. About Yahoo Finance: At Yahoo Finance...
Walgreens shares move higher after posting better-than-expected fiscal second-quarter results
CNBC's Bertha Coombs reports on Walgreen's quarterly earnings results.
Walgreens Profits Dip To $703 Million On Lower Covid ‘Vaccine And Testing Volumes'
Walgreens quarterly profits fell more than 20% to $703 million thanks to “lower COVID-19 vaccine and testing volumes.”
Walgreens Stock Rises on Earnings Beat
The retail pharmacy posts second-quarter adjusted earnings of $1.16 a share, topping analysts' expectations of $1.10.
Walgreens revenue rises despite sharp decline in demand for Covid tests, vaccines
Walgreens' quarterly results topped Wall Street's expectations, even as profit declined from a year earlier.
Walgreens Boots Alliance Reports Fiscal 2023 Second Quarter Results
DEERFIELD, Ill.--(BUSINESS WIRE)--WBA today announced financial results for the second quarter of fiscal 2023.
Walgreens Boots (WBA) Benefits From Innovation Amid Margin Woe
Walgreens Boots' (WBA) comparable pharmacy sales decline reflects lower demand for COVID-19 services.
Dividends, Short-Term Pain, but Long-Term Gain?
Dividend stocks drop by the dividend amount on the ex-dividend date. The stock takes a short-term hit, but the shareholders are compensated in cash on the payout date.
Is a Surprise Coming for Walgreens Boots Alliance (WBA) This Earnings Season?
Walgreens Boots Alliance (WBA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What To Expect From Walgreens' Q2?
Although we expect the company to post a downbeat Q2, we believe its stock has more room for growth, as discussed below Our interactive dashboard analysis on Walgreens Earnings Preview has additional ...
Walgreens Boots Alliance (WBA) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Walgreens (WBA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Trending Stock Walgreens Boots Alliance, Inc. (WBA) a Buy Now?
Recently, Zacks.com users have been paying close attention to Walgreens (WBA). This makes it worthwhile to examine what the stock has in store.
Here's Why You Should Retain Walgreens Boots (WBA) For Now
Investors are optimistic about Walgreens Boots (WBA), backed by continued partnership growth and a strong focus on strategic execution.
7 Blue-Chip Stocks to Buy at an All-Time Low
Although the biggest and most-established enterprises generally outperform smaller firms during troubled times, this concept doesn't always ring true, meaning that speculators can target beaten-down b...
California not renewing $54 million contract with Walgreens amid abortion drug controversy
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss news that California will not be renewing its $54 million contract with retail company Walgreens amid the ongoing controversy surroundin...